Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
-
Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts
-
The Simply Good Foods Company Reports Fiscal First Quarter 2026 Financial Results and Reaffirms Fiscal Year 2026 Outlook
-
Kootenay Reports Results from Nine Holes in Ongoing Columba Drill Program
-
Mayfair Delivers Robust Pre-Feasibility Study for the Fenn-Gib Gold Project
-
San Antonio's 'The Mortgage Man' Verified as Region's #1 Independent Broker: Justin Wager Sweeps 2024-2025 Awards with 148 IQ Strategy and 155+ Perfect Reviews
-
U.S. Veterans Magazine Opens 2026 With a Powerful January Issue Spotlighting Leadership, Legacy and the Future of Veteran Success
-
Gemba Ignites "Fintech-in-a-Box" Revolution: Launches on Microsoft & Google Marketplaces to Let Any Tech Company Become a Bank in Minutes
-
Replicate Bioscience Awarded Grants to Develop New srRNA Vaccines for HIV and Malaria
-
Probo Medical Names Mike Dilick CEO to Drive Next Phase of Growth
-
Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder
-
Xali Gold Commences Work on Pico Machay Gold Project in Peru
-
'Substantial Shortfall' in Copper Supply Widens as the Race for AI and Growing Defense Spending Add to Accelerating Demand, New S&P Global Study Finds
-
OLD REPUBLIC ANNOUNCES FOURTH QUARTER 2025 EARNINGS CALL
-
RVL Pharmaceuticals Announces Santen Obtains Manufacturing and Marketing Approval in Japan for UPNEEQ® Mini Ophthalmic Solution 0.1%
-
Securely and Seamlessly Efile W-2 and 1099 Forms Directly Through Halfpricesoft
-
EF Adventures Expands Exclusive Cycling Tour Offerings during the Tour de France and Tour de France Femmes avec Zwift for 2026
-
Aronora Appoints Industry Leaders to Drive Next Phase of Growth
-
AIResumeBuilder.com Survey: 9 in 10 Gen Z Can't Imagine Life Without ChatGPT
-
Enara Bio Enters 2026 with Dark Antigen Licensing to Boehringer Ingelheim, Appointment of Chief Medical Officer and Plans to Advance DARKFOX T-cell Engager into First-in-Human Studies
-
Corero Network Security Appoints Michelle Ragusa-McBain as Vice President of Channel Sales
-
Dunlop Aircraft Tyres Appoints Lee Timbrell as Chief Commercial Officer
-
Otis Selected for Major Escalator Modernization Across London Underground Network
-
Karsan Makes a Strong Impact at CES 2026 with Field-Proven Autonomous Solutions
-
InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M
-
TD SYNNEX Reports Record Fiscal 2025 Fourth Quarter Results
-
Neogen Announces Second-Quarter 2026 Results
-
Coincheck Group Signs Agreement to Acquire 3iQ, a Global Pioneer in Digital Asset Investment Solutions
-
VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS
-
Osel Enters Agreement with SWOG Cancer Research Network for First-Ever Pivotal Trial of a Microbiome-Based Therapy in Oncology
-
Bidgely Redefines Energy AI in 2025: From Machine Learning to Agentic AI
-
Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue
-
Protege Raises $30 Million Led by a16z to Unlock Access to Data for AI Development
-
Obita Completes Pre-A Round, Raising Nearly US$30 Million Across Two Rounds
-
Echo Water Unveils the Echo One: An Ultra-Pure Hydrogen Water System
-
GlycoEra Appoints Petra Duda, M.D., Ph.D., as Chief Medical Officer to Advance Precision Immune Degrader Pipeline
-
TransactionTree Appoints Kevin Saum as Chief Executive Officer to Lead Next Phase of Growth
-
Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity
-
Parabilis Medicines Announces Oversubscribed $305 Million Financing to Support Ongoing FOG-001 (zolucatetide) Clinical Development Across a Broad Range of Tumors and Advance Pioneering Pipeline and He
-
VIP Play, Inc. Announces Strategic Entry into Daily Fantasy Sports Market
-
MSC Income Fund Announces Fourth Quarter 2025 Private Loan Portfolio Activity
-
Tubulis Appoints Charles Fuchs, MD as Chief Medical Officer to Lead Clinical Strategy and Pipeline Development
-
Enhanced Digital Group Announces Series A Financing
-
Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen
-
Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra A/S
-
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
-
Main Street Announces Fourth Quarter 2025 Private Loan Portfolio Activity
-
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets
-
Cloopen Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
-
Vertiv Expects Powering Up for AI, Digital Twins and Adaptive Liquid Cooling to Shape Data Center Design and Operations
